GlassScriptPhysician profile
Roberto Navarrete
NPI 1760974299
$11,540.41
in general payments reported to CMS, 2019-2025
24 companies · $2,428 in 2025
The $2,428 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.55 · 2022: $107 · 2023: $3,664 · 2024: $5,326 · 2025: $2,428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,326 · Food and Beverage: $4,422 · Education: $1,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,326.44 |
| Food and Beverage | $4,421.71 |
| Education | $1,670.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,534.90 | 2021-2025 | Ams 700, Solyx Sis System, Tactra |
| Intuitive Surgical, INC. | $2,687.41 | 2024-2025 | |
| Coloplast Corp | $1,378.35 | 2023-2024 | Titan |
| Procept Biorobotics Corporation | $378.17 | 2024-2025 | Aquabeam System |
| Calyxo, INC. | $202.58 | 2025 | Cvac Aspiration System |
| Bluewind Medical | $168.82 | 2024-2025 | Revi |
| Ambu INC. | $163.82 | 2022-2024 | |
| Teleflex LLC | $146.34 | 2024 | |
| Olympus America INC. | $146.27 | 2025 | Soltive |
| Stryker Corporation | $135.78 | 2025 | 1788 |
| Janssen Biotech, INC. | $127.04 | 2025 | Rybrevant, Carvykti, Erleada |
| Sumitomo Pharma America, INC. | $84.84 | 2024-2025 | Orgovyx, Gemtesa |
| Immunitybio, INC. | $56.77 | 2025 | |
| Bioprotect Medical, INC. | $54.29 | 2025 | Bioprotect Balloon Implant System |
| Convatec INC. | $41.76 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $36.89 | 2025 | Posluma |
| Novartis Pharmaceuticals Corporation | $35.95 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $31.88 | 2024-2025 | Adstiladrin |
| Laborie Medical Technologies Corp. | $29.45 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Davol INC. | $24.58 | 2025 | Arista |
| Sanara Medtech INC. | $21.34 | 2025 | Biasurge |
| Photocure INC | $20.60 | 2025 | Cysview |
| Urogen Pharma, INC. | $17.04 | 2025 | |
| Myriad Genetic Laboratories, INC. | $15.54 | 2025 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Navarrete listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.